ractigen In Company News, Homepage News, News Highlight04/26/24 Ractigen Therapeutics Announces FDA Approval for RAG-01, a First-in-Class saRNA Therapy for BCG-Unresponsive NMIBC JIANGSU, China, April 26, 2024 — Ractigen Therapeutics, a leader in the development of small…Read More